Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents

Zinn, 2004, Microb. Drug Resist., 10, 160, 10.1089/1076629041310055

Mainous, 2011, Public Health. Rep., 126, 354, 10.1177/003335491112600309

Sabirova, 2010, Klin. Microb. Antimicrob. Ter., 12, 77

Reshedko, 2008, Klin. Microb. Antimicrob. Ter., 10, 96

Borg, 2007, J. Antimicrob. Chemother., 60, 1310, 10.1093/jac/dkm365

Eksi, 2011, J. Microbiol. Immunol. Infect., 44, 57, 10.1016/j.jmii.2011.01.011

Johnson, 2011, J. Antimicrob. Chemother., 66, iv43, 10.1093/jac/dkr474

Kalan, 2011, Expert Rev. Mol. Med., 13, e5, 10.1017/S1462399410001766

10.1016/j.tibtech.2010.07.006

10.1016/j.toxlet.2007.10.004

10.1016/j.watres.2010.06.069

Haggstrom, 2010, Nanoscale., 2, 399, 10.1039/B9NR00245F

Huang, 2009, Small, 5, 51, 10.1002/smll.200801042

10.1016/j.colsurfb.2010.04.014

10.1128/AAC.01830-09

Singh, 2008, Digest. J. Nanomater. Biostructures., 3, 115

10.1093/jac/dkm006

Maple, 1992, J. Antimicrob. Chemother., 9, 661, 10.1093/jac/29.6.661

10.1517/13543784.13.8.1045

10.2147/IJN.S596

Liu, 2009, Curr. Drug Metab., 10, 875, 10.2174/138920009790274522

Pissuwana, 2011, J. Contr. Release, 149, 65, 10.1016/j.jconrel.2009.12.006

10.1002/smll.200700595

10.1016/j.toxlet.2005.08.007

10.1016/j.tox.2008.02.011

Verma P. Methods for determining bactericidal activity and antimicrobial interactions: synergy testing, time–kill curves, and population analysis. In:Antimicrobial Susceptibility Testing Protocols. Schwalbe R, Steele-Moore L, Goodwin AC (Eds). CRC Press, New York, NY, USA, 275–290 (2007).

Fayaz, 2009, Nanomedicine, 6, 103, 10.1016/j.nano.2009.04.006

10.1002/jbm.b.31615

10.1016/j.nano.2007.02.001

10.1111/j.1472-765X.2008.02510.x

10.4236/jbnb.2010.11005

Thati, 2010, J. Biosci. Tech., 1, 64

10.1007/s11671-009-9316-8

10.1088/0957-4484/16/9/082

10.1021/ja1028843

Ruden, 2009, Antimicrob. Agents Chemother., 53, 3538, 10.1128/AAC.01106-08

10.1016/j.biomaterials.2008.09.020

10.1021/nl034396z

10.1128/AEM.02218-06

Rezaei-Zarchi, 2010, Iran J. Pathol., 5, 83

10.1590/S0103-50532010000600002

10.1016/j.jcis.2009.03.018

Asahara, 2009, Jpn J. Infect. Dis., 62, 378, 10.7883/yoken.JJID.2009.378

10.1021/es803093t

10.1021/es1010779

Jiang, 2010, Colloids Surf. B Biointerfaces, 79, 69, 10.1016/j.colsurfb.2010.03.031

10.1111/j.1525-1594.2007.00530.x

10.1021/es101343c

Liu, 2010, Colloids Surf. B Biointerfaces, 78, 171, 10.1016/j.colsurfb.2010.02.024

Jones, 2008, FEMS Microbiol. Lett., 279, 71, 10.1111/j.1574-6968.2007.01012.x

Hooper, 2005, Clin. Infect. Dis., 40, 1811, 10.1086/430381

Huang, 2009, Zh. Anal. Khim., 64, 754

Pissuwan, 2010, Trends Biotechnol., 28, 207, 10.1016/j.tibtech.2009.12.004

Amin, 2009, Nanomedicine (Lond.), 4, 637, 10.2217/nnm.09.50

Chamundeeswari, 2010, Biotechnol. Appl. Biochem., 55, 29, 10.1042/BA20090198

10.1002/ffj.1904

Fisher, 2009, Br. J. Biomed. Sci., 66, 180, 10.1080/09674845.2009.11730270

Luqman, 2007, Altern. Ther. Health Med., 13, 54

10.3390/molecules15129252

Sadlon, 2010, Altern. Med. Rev., 15, 33

Woollard, 2007, J. Wound Care, 16, 255, 10.12968/jowc.2007.16.6.27064

10.1590/S1678-91992010000300006

10.1002/bit.22363

Hu, 2009, J. Biomed. Mater. Res. A, 90, 874, 10.1002/jbm.a.31871

10.1016/j.colsurfb.2010.01.026

Taylor, 2011, Int. J. Nanomed., 6, 1463, 10.2217/nnm.11.123

Xing, 2003, Chem. Commun., 17, 2224, 10.1039/b305886g

Senekal, 2010, CME, 28, 54

Chakraborty, 2010, Nanotechnology, 21, 105103, 10.1088/0957-4484/21/10/105103

10.1016/j.procbio.2010.11.001

10.1007/s00253-005-0179-3